Fibromuscular dysplasia

From IDWiki
Revision as of 17:55, 15 October 2021 by Aidan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

  • Non-inflammatory, non-atherosclerotic fibroplastic disorder
  • Far more common in women (90% of cases)

Clinical Manifestations

  • Arteries involved:
    • Renal 58%
    • Carotid or vertebral 32%
    • Other arteries including iliac and intracranial 10%

Renal Artery FMD

  • Hypertension, especialy early-onset <35 years or drug-resistant
    • Average age of onset 43 years
  • Epigastric or flank bruit
  • Flank pain if dissection or aneurysm
  • Progression to end-stage renal disease is rare

Cerebrovascular FMD

  • Headache is most common complaint, usually migrainous
  • Pulsatile tinnitus
  • Dizziness or lightheadedness
  • Cervical bruit
  • Neck pain
  • TIA or stroke
  • Carotid and vertebral artery dissections, presenting with headache and neck pain, cranial nerve deficits, or Horner syndrome
  • Can cause cerebral aneurysms

Mesenteric FMD

  • Rare, often incidental finding
  • Can cause mesenteric ischemia

FMD of the extremities

  • Most commonly the external iliac arteries, though can involved brachial arteries as well
  • Often asymptomatic, or claudication; rarely, acute ischemia
  • May have a lower abdominal or inguinal bruit

FMD of the Coronary Arteries

  • Can present as an acute coronary syndrome, though rare

Differential Diagnosis

Diagnosis

  • CT or MR angiography (or Duplex ultrasound, if CT unavailable)
    • Measures a gradient
  • Previously would use captopril renal scan

Management

Renal Artery Revascularization

  • Recurs in 50-60%

Indications

  • Resistant hypertension despite 3-drug regimen including diuretic
  • Recent-onset hypertension, with the goal of curing it
  • Renal artery dissection (needs stenting)
  • Renal artery aneurysm
  • Branch renal artery disease and hypertension
  • Preservation of renal function if severe stenosis

Chronic

  • Low-dose ASA recommended for all patients

Screening

  • All patients with FMD anywhere are recommended to be screened for intracranial aneurysms with CTA or MRA
  • Carotid, coronary, vertebral aneurysms all possible, so likely useful to do whole-body CTA

Hypertension

  • First-line is ACEi/ARB
  • Can consider percutaneous transluminal angioplasty

Dissection

  • LMWH or wardarin for 3 to 6 months, or antiplatelet therapy

Follow-up

  • Monitor blood pressure and creatinine every three months, then annually if stable
  • Duplex ultrasound or other noninvasive imaging of the involved arteries every 6 to 12 months

Further Reading